Stockreport

TuHURA Biosciences, Inc. Announces Abstracts Accepted for Poster Presentation at the 2025 AACR Annual Meeting [Yahoo! Finance]

TuHURA Biosciences, Inc.  (HURA) 
PDF technologies to overcome resistance to cancer immunotherapy, today announced that an abstract highlighting Kineta Inc.'s novel KVA12123 antibody and an abstract from Mof [Read more]